Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors-Reference-Cited by-同舟云学术

Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors

Published:1999-05 Issue:2 Volume:55 Page:167-175
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Ménard Sylvie,Casalini Patrizia,Tomasic Gorana,Pilotti Silvana,Cascinelli Natale,Bufalino Rosaria,Perrone Franco,Longhi Chiara,Rilke Franco,Colnaghi M. Ines

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1006262324959

Reference25 articles.

1. McGuire WL, Clark GM: Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326: 1756–1761, 1992

2. Clark GM: Do we really need prognostic factors for breast cancer? Breast Cancer Res Treat 30: 117–126, 1994

3. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 14: 2843–2877, 1996

4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182, 1987

5. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U: p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85: 965–970, 1993

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse Mammary Tumor Virus (MMTV) and MMTV-like Viruses: An In-depth Look at a Controversial Issue;Viruses;2022-05-06

2. Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer;BMC Cancer;2018-04-03

3. Prognostic Significance of Deregulated Dicer Expression in Breast Cancer;PLoS ONE;2013-12-30

4. Klassifikatsii protokovogo raka in situ molochnoy zhelezy;Russian Journal of Oncology;2010-06-15

5. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers;Breast Cancer Research;2009-03-09